The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy

Personalized genetic profiling has focused on improving treatment efficacy and predicting risk stratification by identifying mutated genes and selecting targeted agents according to genetic testing. Therefore, we evaluated the role of genetic profiling and tumor mutation burden (TMB) using next-gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui-Ching, Moi, Sin-Hua, Chan, Leong-Perng, Wu, Chun-Chieh, Du, Jeng-Shiun, Liu, Pei-Lin, Chou, Meng-Chun, Wu, Che-Wei, Huang, Chih-Jen, Hsiao, Hui-Hua, Pan, Mei-Ren, Chen, Li-Tzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238468/
https://www.ncbi.nlm.nih.gov/pubmed/37121970
http://dx.doi.org/10.1038/s12276-023-00984-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238468/
https://www.ncbi.nlm.nih.gov/pubmed/37121970
http://dx.doi.org/10.1038/s12276-023-00984-4

Ejemplares similares